Top Links

Articles Related to cancer

The Contribution of Alcohol Consumption to Overall Cancer Incidence in the Western World: A Meta-Analysis

The effect of alcohol consumption on overall cancer incidence is not clear. The aim of the paper is to estimate the impact of alcohol consumption on risk distribution of the 20 most common cancer types among men and women in the Western world. A meta-analysis of relative risks for the 20 most common cancer types potentially associated with alcohol consumption in the Western world was conducted based on the most recent cancer specific meta-analyses. Cancer risks were compared between men and women applying a sigmoidal dose response model. Drinking 2.5-14.9 g alcohol/day was associated with a small decrease in overall cancer incidence: 0.977 for men and 0.974 for women; followed by a small increase in the 15-29.9 g/day category: 1.029 for men and 1.077 for women. Further increases were observed in the 30-60 g/day category indicating a 5 and 10% increase in overall cancer risk for men and women, respectively. Women appeared to be more sensitive: the alcohol consumption level to acquire overall risk increase is 22 g/day for women and 46 g/day for men.
View complete article: PDF  |  Full-text

Recent Advancements Involving Immunoliposomes to Target Breast Cancer

Breast cancer is caused by genetic abnormalities resulting in uncontrolled growth of breast cells, and is the most commonly diagnosed cancer amongst women. The clinical use of liposomal-based drugs to treat solid tumors such as breast cancer has been shown to improve the overall pharmacological properties of otherwise “unencapsulated” cytotoxic agents.
View complete article: PDF  |  Full-text

Cisplatin-Gemcitabine Related Cardiomyopathy in Non-Small Cell Lung Cancer NSCLC Patient: A Case Study

Gemcitabine is a pyrimidine analog and cisplatin is a platinum agent, they are usually combined to form a chemotherapeutic doublet used to treat different types of oncological cancers, including non-small cell lung cancer (NSCLC). Although these agents are not known to cause such events, few cases related to possible cardiotoxicity side effects have been reported ; including angina, chronic heart failure, arrhythmias, and cardiac ischemia. A 52-year-old African male presented with Stage IV lung adenocarcinoma metastatic to the bone, pleura and lymph node, EGFR wild type. Patient has a history of hypertension, diabetes, and atrial fibrillation and on rate control medications. He was treated initially with cisplatin-gemcitabine, after which he developed cardiomyopathy.
View complete article: PDF  |  Full-text

Clinical Significance of microRNA Polymorphisms and Expression Profiles in Oral Cancer Development

MicroRNAs (miRNA) are potent regulators, controlling multiple biological processes, including cell growth, differentiation, cell death, development and immune responses. With emerging data supporting that miRNAs play a central role in gene dysregulation in human malignancies, unraveling the miRNA genetic variations in cancer is essential and critical if we want to develop better diagnostic and prognostic system for our patients.
View complete article: PDF  |  Full-text

Quality of Life after Accidental Major Vascular Injury and Prolonged ICU Stay - A Case Report

Survival or mortality rate is a reasonable choice of an outcome measure for critically ill patients in intensive care unit (ICU). But it is also important to assess the impact of critical illness and peri-operative complications on health status and quality of life (QoL) after hospital discharge. The QLQ-C30 is a 30-item cancer-specific questionnaire that incorporates five functioning scales (physical, role, cognitive, emotional, and social), eight symptoms scales, perceived financial impact of the disease and a global scale [1-5].
View complete article: PDF  |  Full-text

Screening & Awareness of Breast Cancer in an Urban Slum of Pakistan: A Pilot Study

Background: Breast cancer is the most common cancer in women across the world with low survival rates in less developed countries. Low survival rates in less developed countries can be explained mainly by the lack of early detection programs and lack of adequate diagnosis and treatment facilities.
View complete article: PDF  |  Full-text

Tomotherapy Treatment of Chronic Lymphocytic Leukemia and Ocular Lymphoma

A sixty-five-years-old male patient with history of non-Hodgkin’s lymphoma of the right orbit and a fifty-years-old female patient with chronic lymphocytic leukemia with peripheral lymphocytosis were treated on TomoTherapy. In the first case, a 1 cm beam was used for planning a delivery of 30.6 Gy in 17 fractions with a sequential boost of 9 Gy in 5 fractions. Tumor involvement of the ipsilateral lens and lacrimal gland in the planning target volume necessitated a compromise between preserving patient’s vision and delivery of tumoricidal dose to the target. In the second case, 30 Gy in 20 fractions delivery was planned with a 2.5 cm beam. The tumor extended anteriorly and this technique allowed sparing more orbital tissue and required a high modulation factor.
View complete article: PDF  |  Full-text

The Role of Ovarian Varicose Veins and Varicocele in Cancer and Venous Thrombosis

Varicose veins next to the testicles and the ovaries are associated with oxidative stress, which can change the phenotype of germinating glands, provoking abnormalities in the hypothalamic-pituitary-gonadal axis. This creates an interference that can express itself in the form of gene mutations in patients with cancer and venous thrombosis. In this study, we made it our goal to evaluate the prevalence of ovarian varicose veins and varicocele in patients with cancer and venous thrombosis and to further investigate this association. In order to achieve this objective, 54 patients with cancer and 98 patients in the control group diagnosed with venous thrombosis were included in this study. All of these patients were examined through ultrasound with vascular Doppler as a means to investigate varicocele in men and ovarian varicose veins in women. Out of a total of 14,800 patients, 152 with cancer and venous thrombosis were selected (1.02%). The group with cancer presented a significantly (p = 0.0029) higher proportion of varicose veins (96.3%) next to the germinating glands than the group with venous thrombosis (84.7%).
View complete article: PDF  |  Full-text

Mechanisms of Resistance to Kinase Inhibitors and Strategies to Prevent the Development of Drug Resistance

Targeting mutant proteins and associated signaling pathways of driver oncogenes by small molecule kinase inhibitors (KIs) are a promising strategy of cancer therapy. However, despite the initial success of treatment, KIs often become ineffective as intrinsic and acquired resistance. This article reviews the English-language literature to explore the underlying mechanisms of drug resistance and to present a challenge for developing drugs to overcome resistance. Mechanisms of acquired resistance include 1) the selection of pre-existing subclones with other mutations, 2) the emergence of secondary mutations in the target kinase domain, 3) upregulation of kinases both within the same kinase family and their related kinase families, as well as activation of alternative bypass pathways, 4) epithelial-mesenchymal transition, 5) overexpression of pro-survival Bcl-2 family proteins and 6) drug efflux mechanisms. Currently available methods are to obtain tumor biopsy samples at recurrence or progression if the tumor lesion is accessible to a biopsy and to use the second- and third-generation KIs based on the individual need of each patient. Furthermore, recent computational challenges provide design principles to prevent the development of drug resistance. In conclusion, we provide an overview of the postulated resistance mechanisms and highlight the future direction of computational structure-based design of new potent KIs.
View complete article: PDF  |  Full-text

Former Effective Immunotherapy without Adverse Events of Inoperable Epithelial Ovarian Cancers and a Prospect for the Immune Prophylaxis

Current cancer treatments by immune checkpoint blockades are limited due to severe adverse events caused by alteration of the immune system required for homeostasis of normal tissues. Common cancer chemotherapy alters the quality of patients’ lives. Platinum-based treatment can lead to severe neurotoxicity with chronic debilitation. Additionally, survival of patients with epithelial ovarian cancers (EOCs) has remained poor despite extensive cytoreductive surgery, high dose chemotherapy, checkpoint blockades and immunotherapies effective in some other types of cancer. The pathobiology of EOC cancer stem cells (CSCs) is not well understood. Observations demonstrate that EOCs exhibit in vivo two distinct CSC types - perivascular diploid CSCs dividing asymmetrically with the help of the host suicidal CD8+ T cells, and haploid CSCs at the cancer abdominal surface originating from meiosis I cytokinesis of bulk surface cancer cells. The perivascular CSCs contribute to the cancer cell bulk and, via left ovary venous blood, can cause EOC liver metastases. Haploid CSCs released from the bulk cancer surface cause the common pelvic and abdominal EOC spread. Former elimination of the host antibodies blocking T cell effectors by intermittent doses of cyclophosphamide exhibiting significant immunomodulatory anticancer effects, facilitation of the immune system reactivity against alloantigens of cancer cells by blood transfusions, and augmentation of anticancer immunity by bacterial toxins, resulted during the subsequent treatment-free period into rejection of inoperable EOCs without any adverse events during the treatnment. To help prevent cancer relapses, patients treated for advanced primary epithelial cancers should be considered as candidates for continuously stimulating immune anticancer activity by treatments such as daily metformin and weekly lentinan consumptions.
View complete article: PDF  |  Full-text

Thyroid Cancer Incidence and Clinicopathological Differences in Patients with End-Stage Renal Failure

Aim: In the present study we aimed to determine the prevalence of thyroid cancer and the clinicopathological properties of papillary thyroid cancer (PTC) in a patient population undergoing dialysis for end-stage renal failure (ESRF). Material and Methods: We retrospectively reviewed all thyroid ultrasonography (USG) examinations performed between January 2007 and December 2015 to determine the incidence of nodular thyroid disease in ESRF and normal patient populations. For both patient groups, differences between patient and tumor characteristics were evaluated in patients diagnosed to have PTC.
View complete article: PDF  |  Full-text

Two-Dimensional Infrared Correlation Spectroscopy, Linear Two-Dimensional Infrared Spectroscopy and Non-Linear Two-Dimensional Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time

In the current study, we have experimentally and comparatively investigated and compared malignant human cancer cells and tissues before and after irradiating of synchrotron radiation using Two-Dimensional Infrared Correlation Spectroscopy, Linear Two-Dimensional Infrared Spectroscopy and Non-Linear Two-Dimensional Infrared Spectroscopy.
View complete article: PDF  |  Full-text

Scalp, Skull, Lung and Bone Metastasis from Follicular Thyroid Carcinoma - A Rare Case Report

Concurrent scalp, skull, lung and bone metastasis from follicular thyroid carcinoma is a very rare event. We herein present the case of a 37- year’s old lady, who presented to us with huge scalp swelling that proved to be metastasis from a follicular thyroid carcinoma. The metastatic workup disclosed bilateral lung metastasis and additional metastasis in right iliac crest and 6th rib. The course of her disease was relentless. Although follicular thyroid carcinoma has an excellent prognosis, the presence of metastatic disease leads to a very dismal prognosis.
View complete article: PDF  |  Full-text

A Nutrition and Physical Activity Education Model for Cancer Risk Reduction Improves Knowledge and Dietary Behaviors among Students in the Alabama Black Belt

An age-appropriate, culturally sensitive Nutrition and Physical Activity Education Model (NPAEM) for cancer risk reduction was developed and implemented. NPAEM was underpinned by the social-cognitive theory. Participants (N=86) were 8 to 11-year-old students from public elementary schools in Macon County, Alabama. The NPAEM comprised of 11 topics and activity/worksheets. Lesson plans, evaluation and hands-on activity/worksheets were developed. The 15-week intervention was cross-sectional, with a pre- and post-assessment design and weekly 45-minute lessons.
View complete article: PDF  |  Full-text

The Influence of Faith and Religiosity in Coping with Breast Cancer

The study researches the influence of faith and religiosity in coping with breast cancer based on the analysis of spiritual well-being and the association of spirituality/religiosity and its practices with the acceptance of diagnosis, treatment adherence and future prospects for the patient. A descriptive and field research carried out with patients diagnosed with breast cancer resulted in the evident conclusion that faith and religiosity present themselves as the determinant, potent and active factors in their clinical treatments and in their lives.
View complete article: PDF  |  Full-text


Editorial Board Members Related to cancer

GIRJA SHANKER SHUKLA

Associate Professor
Department of Surgery
University of Vermont College of Medicine
United States

Gregory Kouraklis

Professor of Surgery
National and Kapodistrian University
President of Athens Medical Society
Greece

Daniela Iannazzo

University Researcher
Department of Electronic Engineering, Industrial Chemistry and Engineering
University of Messina
Italy

RICHARD G. MOORE

Professor
Department of Obstetrics and Gynecology
Warren Alpert Medical School
Brown University
United States

Sanja Ilic

Assistant Professor
Department of Human Nutrition
The Ohio State University
United States

JANAK PADIA

Associate Professor
Center of Biomolecular Therapeutics
University of Maryland
United States

Dagmara McGuinness

Research Associate
College of Medical
Veterinary & Life Sciences
Institute of Cancer Sciences
Western Infirmary Glasgow
Scotland

DAVID GABBAIZADEH

Department of Gastroenterology, Hepatology & Nutrition
Huntington Medical Group
United States

P. S. SURESH

Assistant Professor
Department of Bio-Sciences
Mangalore University
India

MD Ibrahim El Said Ali El-Gamal

Assistant Professor
College of Pharmacy
Department of Medicinal Chemistry
University of Sharjah
UAE
Submit Manuscript